GlobeNewswire🇺🇸 US
Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update
Type A Meeting Scheduled with FDA to Potentially Clarify Path to GTx-104 NDA Resubmission
News/Grace Therapeutics Announces 2026 Fiscal Year-En…